ECM
BIO icon

Exchange Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Exchange Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-18
Closed -$2K – 107
2014
Q4 		$2K Buy
+18
New +$2.07K ﹤0.01% 266

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Exchange Capital Management's BIO Position: Q1 2015 in Review

Exchange Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2015, closing a stake of 18 shares — an estimated $2K sold.

Exchange Capital Management first reported a position in BIO in Q4 2014 and held it in 1 quarter. The position peaked at $2K in Q4 2014. 219 funds tracked by Wall St. Rank hold BIO as of Q1 2015.

  • Exchange Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2015 after selling out during the quarter.
  • Exchange Capital Management sold 18 Bio-Rad Laboratories Class A shares in Q1 2015, an estimated $2K.
  • Exchange Capital Management first reported a position in Bio-Rad Laboratories Class A in Q4 2014 and held it in 1 quarter.
  • Exchange Capital Management's Bio-Rad Laboratories Class A position peaked at $2K in Q4 2014.
  • 219 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2015.

Based on Exchange Capital Management's 13F filing for Q1 2015, filed 17 Apr 2015.